Article Information
History
- August 20, 2020.
Article Versions
- Version 1 (May 13, 2020 - 03:38).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Can Liu1,
- Vivaswath S. Ayyar2,
- Xirong Zheng2,
- Wenbo Chen2,
- Songmao Zheng2,
- Hardik Mody2,
- Weirong Wang3,
- Donald Heald2,
- Aman P. Singh2,* and
- Yanguang Cao1,4,*
- 1Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA
- 2Discovery and Translational Research, Biologics Development Sciences, Janssen Biotherapeutics, Spring House, PA, USA
- 3Clinical Pharmacology and Pharmacometrics, Janssen Research & Development, Spring House, PA, USA
- 4Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- ↵*co-corresponding authors
Aman P. Singh: asing215{at}its.jnj.com Yanguang Cao: yanguang{at}unc.edu
Posted August 20, 2020.
Model-based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in Humans
